Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
about
Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Osteoglycin (OGN) reverses epi ...... l cancer via EGFR/Akt pathway.
@en
Osteoglycin
@nl
type
label
Osteoglycin (OGN) reverses epi ...... l cancer via EGFR/Akt pathway.
@en
Osteoglycin
@nl
prefLabel
Osteoglycin (OGN) reverses epi ...... l cancer via EGFR/Akt pathway.
@en
Osteoglycin
@nl
P2093
P2860
P1476
Osteoglycin (OGN) reverses epi ...... l cancer via EGFR/Akt pathway.
@en
P2093
Jun-Jie Peng
Qing-Guo Li
San-Jun Cai
Yan-Lei Ma
P2860
P2888
P356
10.1186/S13046-018-0718-2
P577
2018-03-02T00:00:00Z
P6179
1101304995